“Modification and Characterization of Some New Levofloxacin Heterocyclic Derivatives as COX-2 Enzyme Inhibitors and Evaluate Their Efficacy Pharmacokinetics by Molecular Docking and the Swiss ADME Studies”, Baghdad Sci.J, vol. 21, no. 4, p. 1255, Apr. 2024, doi: 10.21123/bsj.2023.8295.